Novavax COVID-19 Vaccine Now FDA Approved for People 18 and Above, Protein-Based Jab Has Less Side Effects

Medicine & Technology Jul 15, 2022

The FDA authorized Novavax to inject its COVID-19 vaccine into individuals aged 18 years old and above. Read to know its difference from other similar vaccines.

Novavax COVID-19 Vaccine Effective Against All Mutations Including Omicron

Jun 30, 2022

Novavax, despite speed bumps in the past, has just released data that suggests it's effective against all circulating covid-19 variants. Read on to find out what set's the Novavax vaccine apart from other mRNA vaccines and what the FDA has to say about it.

Novavax COVID-Flu Vaccine Shows Positive Results from Initial Trials; Formulation ‘Safe with Mostly Mild Side Effects’

Apr 21, 2022

Novavax announced its COVID-Flu vaccine is seen positive results from the phase I trials. Learn more about the efficacy of the vaccine and what lies ahead.

A 5th COVID-19 Shot Soon? Here’s an Update on the EU-Approved Novavax Vaccine

Dec 21, 2021

The European Medicines Agency has cleared the way for a fifth authorized COVID-19 jab that authorizes its use in adult individuals who are 18 years old and above.

How Does Novavax COVID-19 Vaccine Work?

Apr 19, 2021

The Novavax vaccine works like other COVID-19 vaccines by teaching the immune system to make antibodies to the coronavirus spike protein.

Novavax Covid-19 Vaccine Enters Late Stage Trials

Nov 04, 2020

Around this time last year, the small company of Novavax was on the verge of closing down. Today, they are one of the world's leading developers of the coronavirus vaccine.

Novavax To Begin Phase 3 of Trials, Hopes To Soon Combine COVID-19 and Flu Vaccines

Sep 25, 2020

Novavax's vaccine candidate has produced the highest number of antibodies according to vaccine experts. As they enter the final stage of human trials, they will also be testing some participants with the flu vaccine at the same time.